Joe Maskell

TL;DR: The economic burden of COPD is considerable across countries, and requires targeted resources to optimise COPD management encompassing the control of symptoms, prevention of exacerbations and effective treatment of comorbidities.

TL;DR: Blood eosinophil count may be a useful biomarker for predicting response to inhaled corticosteroids and exacerbation risk in chronic obstructive pulmonary disease patients and matched non-COPD controls, although there was substantial overlap in the distributions.

TL;DR: Poor patient engagement and medication adherence are frequent and associated with worse COPD-specific health status, higher health care utilization, and lower satisfaction with health care providers.

TL;DR: Improved practices for identifying HH in clinical settings may increase the sensitivity and specificity of future studies and improve characterization and quantification of the population burden of this significant disease.

TL;DR: In this article, the authors specify diagnostic, symptom, and prescription codes for hyperhidrosis to estimate incidence and prevalence for the United Kingdom and the United States, and find that women accounted for approximately 60% of incident and prevalent cases in both countries.